⏳ Fetching live dividend data...
Home › Calculator › CSCI Dividend Calculator 2026
COSCIENS Biopharma Inc. · NASDAQ
Price: $2.72 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
CSCI is not a dividend-focused stock
CSCI pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
COSCIENS Biopharma Inc. (CSCI) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
COSCIENS Biopharma Inc. is a specialized biopharmaceutical company dedicated to the global development and commercialization of innovative therapeutic and diagnostic products. Its operations extend across Canada, Switzerland, Ireland, Denmark, Germany, the United States, and other international territories. The company's flagship product is Macrilen (macimorelin), an orally administered peptidomimetic ghrelin receptor (GHSR-1a) agonist. This compound works by stimulating growth hormone secretion through its interaction with the GHSR-1a receptor, primarily serving for the diagnosis of both adult and childhood-onset growth hormone deficiency. It also shows promise in other endocrinology and oncology applications. Its pipeline includes AEZS-150, a delayed-clearance parathyroid hormone fusion polypeptide currently undergoing preclinical evaluation for the management of chronic hypoparathyroidism. Another preclinical candidate, AEZS-130, is being investigated for its potential in treating amyotrophic lateral sclerosis (ALS). COSCIENS has established a license and research collaboration with the University of Wuerzburg. This partnership aims to develop, produce, and market AIM biologicals targeting neuromyelitis optica spectrum disorder, alongside conducting preclinical research into their potential for Parkinson's disease treatment. To further its commercial efforts for Macrilen, the company has licensing agreements with Consilient Health Ltd. and NK MEDITECH Ltd. for its development and commercialization, as well as a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood specifically for Macrilen's diagnostic application in pediatric and adult growth hormone deficiency. Further collaborations include an agreement with The University of Sheffield in the United Kingdom, focused on the development, manufacturing, and commercialization of parathyroid hormone fusion polypeptides designed to address chronic hypoparathyroidism. Originally incorporated in 1990 as Aeterna Zentaris Inc., the company officially rebranded as COSCIENS Biopharma Inc. in August 2024. Its corporate headquarters are located in Toronto, Canada.
No. COSCIENS Biopharma Inc. (CSCI) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. CSCI has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CSCI position with:
Real after-tax yield depends on where you live and how you hold CSCI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CSCI pays quarterly — 4 times per year. Ex-div: —.
How CSCI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CSCI sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare CSCI with peers: CSCI vs AIFU · CSCI vs DIDAF · CSCI vs LFCR
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CSCI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
COSCIENS Biopharma Inc. (CSCI) is currently trading at $2.72, 41% below its 52-week high. It does not currently pay a regular dividend.
COSCIENS Biopharma Inc. (CSCI) is a healthcare stock trading at $2.72. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only — not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever